NPI: 1104893221 · MELBOURNE, FL 32904 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 102 | $70.08 |
| 2019 | 4,105 | $423K |
| 2020 | 14,622 | $1.52M |
| 2021 | 13,184 | $424K |
| 2022 | 10,476 | $1.24M |
| 2023 | 5,380 | $356K |
| 2024 | 2,853 | $152K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,824 | 1,252 | $1.63M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 16,527 | 780 | $1.24M |
| A4657 | Syringe, with or without needle, each | 2,891 | 878 | $505K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,412 | 415 | $368K |
| J1756 | Injection, iron sucrose, 1 mg | 2,576 | 504 | $108K |
| 85041 | 597 | 381 | $46K | |
| 85048 | 592 | 379 | $45K | |
| 83550 | 557 | 361 | $42K | |
| 83540 | 556 | 361 | $42K | |
| 82728 | 542 | 349 | $39K | |
| 83970 | 380 | 243 | $31K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 159 | 75 | $12K |
| 82746 | 20 | 13 | $1K | |
| 82108 | 39 | 26 | $1K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 50 | 25 | $1K |